4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-26-110340
Chief Financial Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
David Matthew T · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-14 | Grant or award : show line 1 in the form | +250,000 | 250,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-14 | Grant or award : show line 2 in the form Stock Option (right to purchase) | +250,000 | 250,000 | D |
Loading xslF345X06/ownership.xml…